SRPT

Sarepta Therapeutics Inc
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$1.77B
P/E Ratio
48.00
EPS
$0.35
Beta
0.26
52W High
$43.92
52W Low
$10.42
50-Day MA
$20.05
200-Day MA
$19.98
Dividend Yield
Profit Margin
2.98%
Forward P/E
5.46
PEG Ratio
159.25

About Sarepta Therapeutics Inc

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$2.18B
Gross Profit (TTM)$-141.65M
EBITDA$46.18M
Operating Margin49.00%
Return on Equity4.91%
Return on Assets0.02%
Revenue/Share (TTM)$21.41
Book Value$14.26
Price-to-Book1.18
Price-to-Sales (TTM)0.81
EV/Revenue0.988
EV/EBITDA17.26
Quarterly Earnings Growth (YoY)2664.00%
Quarterly Revenue Growth (YoY)-1.90%
Shares Outstanding$105.58M
Float$94.80M
% Insiders4.09%
% Institutions98.97%

Historical Volatility

HV 10-Day
36.19%
HV 20-Day
56.63%
HV 30-Day
49.36%
HV 60-Day
83.33%
HV Rank

Volatility is currently contracting

Analyst Ratings

Consensus ($22.00 target)
8
Buy
12
Hold
3
Sell
2
Strong Sell

More HEALTHCARE Stocks

Data last updated: 5/25/2026